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Abstract. 
 
During microtubule depolymerization, the 
central, juxtanuclear Golgi apparatus scatters to multi-
ple peripheral sites. We have tested here whether such 
scattering is due to a fragmentation process and subse-
quent outward tracking of Golgi units or if peripheral 
Golgi elements reform through a novel recycling path-
way. To mark the Golgi in HeLa cells, we stably ex-
pressed the Golgi stack enzyme 
 
N
 
-acetylgalactosami-
nyltransferase-2 (GalNAc-T2) fused to the green 
fluorescent protein (GFP) or to an 11Ðamino acid 
epitope, VSV-G (VSV), and the 
 
trans
 
/TGN enzyme 
 
b
 
1,4-galactosyltransferase (GalT) fused to GFP. After 
nocodazole addition, time-lapse microscopy of Gal-
NAc-T2ÐGFP and GalTÐGFP revealed that scattered 
Golgi elements appeared abruptly and that no Golgi 
fragments tracked outward from the compact, juxtanu-
clear Golgi complex. Once formed, the scattered struc-
tures were relatively stable in fluorescence intensity for 
tens of minutes. During the entire process of dispersal, 
immunogold labeling for GalNAc-T2ÐVSV and GalT 
showed that these were continuously concentrated over 
stacked Golgi cisternae and tubulovesicular Golgi 
structures similar to untreated cells, suggesting that po-
larized Golgi stacks reform rapidly at scattered sites. In 
fluorescence recovery after photobleaching over a nar-
row (FRAP) or wide area (FRAP-W) experiments, pe-
ripheral Golgi stacks continuously exchanged resident 
proteins with each other through what appeared to be 
an ER intermediate. That Golgi enzymes cycle through 
the ER was confirmed by microinjecting the dominant-
negative mutant of Sar1 (Sar1p
 
dn
 
) blocking ER export. 
Sar1p
 
dn
 
 was either microinjected into untreated or no-
codazole-treated cells in the presence of protein syn-
thesis inhibitors. In both cases, this caused a gradual ac-
cumulation of GalNAc-T2ÐVSV in the ER. Few to no 
peripheral Golgi elements were seen in the nocodazole-
treated cells microinjected with Sar1p
 
dn
 
. In conclusion, 
we have shown that Golgi-resident glycosylation en-
zymes recycle through the ER and that this novel path-
way is the likely explanation for the nocodazole-induced 
Golgi scattering observed in interphase cells.
Key words: Golgi apparatus ¥ endoplasmic reticulum ¥ 
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T
 
he
 
 mammalian Golgi apparatus is the central or-
ganelle within the secretory pathway. It plays an im-
portant role in processing, maturation, and sorting
of newly synthesized secretory and membrane proteins re-
ceived from the ER and in recycling receptors involved in
endocytosis (for reviews see Palade, 1975; Rothman, 1994).
It also has major roles in general complex carbohydrate
and glycolipid biosynthesis and lipid processing. The over-
all distribution of the Golgi apparatus varies considerably
from cell type to cell type and from organism to organism.
In plants and fungi, the individual Golgi units are scattered
about the cytoplasmic volume in a series of flattened sets
of stacked cisternae. In mammalian fibroblasts, on the
other hand, individual Golgi units are clustered together in
a juxtanuclear array, often termed the Golgi ribbon, in
close association with microtubules and the microtubule
organizing center. When visualized by immunofluores-
cence, the Golgi ribbon appears as a lacy structure occupy-
ing a volume of 5Ð7 
 
m
 
m in length, 1Ð2 
 
m
 
m in breadth, and
3Ð5 
 
m
 
m in depth (Storrie and Kreis, 1996). When viewed
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by electron microscopy in single thin sections, the or-
ganelle appears as long ribbons of interconnecting tubules
and stacks of cisternae highly enriched in specific resident
proteins such as glycosyltransferases. In thick sections, the
Golgi complex consists of a flattened set of cisternae with
tubular and vesicular arrays and the whole interconnected
by tubules between cisternal stacks (Rambourg and Cler-
mont, 1990). Golgi cisternae can be distinguished from
one another by their relative content of resident glycosyla-
tion enzymes. In cell fractionation experiments, Golgi cis-
ternae differ slightly in density from one another; enzymes
acting early in the modification of N-linked oligosaccha-
rides are found to be separated, albeit partially, in dis-
tribution from those acting later (Dunphy et al., 1981;
Dunphy and Rothman, 1983). By electron microscopy,
glycosylation enzymes exhibit distinct, but overlapping,
gradient-like distribution patterns (Nilsson et al., 1993;
Rabouille et al., 1995
 
a
 
; Rttger et al., 1998). Whereas
 
b
 
1,4-galactosyltransferase (GalT)
 
1
 
 is found mainly in the
 
trans
 
-cisternae and the TGN, the 
 
O
 
-glycosylation enzyme
 
N
 
-acetylgalactosaminyltransferase-2 (GalNAc-T2) is found
throughout the Golgi stack with a somewhat higher pre-
ference for the 
 
trans
 
-cisternae (Rttger et al., 1998). Hence,
GalT provides a subcompartment-specific marker for the
 
trans
 
/TGN and may be used to assess the polarity of Golgi
stacks, whereas GalNAc-T2 provides a general marker for
the Golgi stack.
The steady-state distribution of Golgi glycosylation en-
zymes is thought to be, in part, the result of recycling, ei-
ther through retrograde transport vesicles, tubular connec-
tions between cisternae, direct transport to the ER, or
some combination of these possibilities (for review see
Nichols and Pelham, 1998). Such recycling is suggested by
the addition of agents such as brefeldin A or nocodazole.
Brefeldin A results in a rapid redistribution of the Golgi
apparatus into the ER (Doms et al., 1989; Lippincott-
Schwartz et al., 1989), while nocodazole induces a slow dis-
persal of the juxtanuclear Golgi to peripheral sites (Cole
et al., 1996
 
a
 
; Yang and Storrie, 1998). Both effects indicate
an underlying recycling pathway through the ER (for re-
view see Storrie and Yang, 1998). A direct test for such
a pathway was carried out recently by the Lippincott-
Schwartz laboratory and demonstrated recycling to the
ER of chimeric proteins that localized to the Golgi (Cole
et al., 1998). In these experiments, the temperature-sensi-
tive domain of vesicular stomatitis virus G protein (VSV-
G
 
ts
 
) provided a trap for chimeric protein accumulation in
the ER at restrictive temperature. Chimeric proteins for
Golgi proteins from the 
 
cis
 
 to 
 
trans
 
 sides all accumulated
in the ER under these conditions. In contrast, work from
the Warren laboratory argues against recycling of Golgi
proteins to the ER (Shima et al., 1998). Microinjection of
the dominant-negative mutant of Sar1 (Sar1p
 
dn
 
), a small
GTPase needed for COP IIÐmediated export out of the
ER, in the presence of nocodazole failed to accumulate in
the ER the 
 
medial
 
 Golgi-resident protein giantin under
conditions where the intermediate compartment marker,
ERGIC53, did. The two opposing lines of evidence, for
and against recycling of Golgi-resident proteins through
the ER, are not easy to reconcile. However, the time
course for the Sar1p
 
dn
 
 experiments was relatively short,
and it remains a distinct possibility that Golgi-resident
proteins recycle through the ER at a slow rate. Such a pos-
sibility would be consistent with the slow kinetics of Golgi
dispersal observed upon nocodazole-induced microtubule
depolymerization.
Here, we have taken the hypothesis that Golgi-resident
glycosylation enzymes do recycle through the ER and that
this explains the slow reformation of Golgi stacks seen at
peripheral sites (Cole et al., 1996
 
a
 
; Burkhardt et al., 1997;
Yang and Storrie, 1998). We have used green fluorescent
protein (GFP)- and epitope-tagged Golgi-resident glyco-
sylation enzymes to examine how individual scattered
Golgi elements form over the full time span of microtu-
bule depolymerization. We have also investigated over
several hours the effect of microinjecting Sar1p
 
dn
 
 on the
possible ER accumulation of cisternal glycosyltransfer-
ases. In testing our hypothesis, we have formulated four
different tests: (
 
a
 
) Scattered Golgi structures (stacks) dur-
ing microtubule depolymerization should form in an epi-
sodic manner, similarly to that of the recently reported
formation of VSV-G
 
ts
 
ÐGFPÐlabeled vesicularÐtubular
structures at ER exit sites (Presley et al., 1997; Scales et
al., 1997). The postulated block in Golgi protein cycling is
at the level of juxtanuclear collection of Golgi structures
and is post-ER exit. (
 
b
 
) Scattered Golgi stacks should ex-
change proteins with one another on a time scale of tens of
minutes in a manner suggestive of an ER intermediate in
the exchange process. (
 
c
 
) Introduction of Sar1p
 
dn
 
 should
lead to ER accumulation of preexisting Golgi membrane
proteins over a matter of hours. (
 
d
 
) Sar1p
 
dn
 
 should inter-
fere with nocodazole-induced Golgi scattering and lead to
the disappearance of scattered Golgi structures as Golgi-
resident proteins now accumulate in the ER. Our overall
aim was to investigate whether or not Golgi cisternal pro-
teins cycle. We found that Golgi elements appeared at
scattered sites in an abrupt manner without any detectable
tracking of fluorescent structures from the juxtanuclear
Golgi complex to peripheral sites. Photobleaching experi-
ments showed that scattered Golgi elements slowly ex-
changed resident proteins. Quantitative morphometric scor-
ing of the distribution of the epitope-tagged Golgi marker
GalNc-T2ÐVSV indicated that, at all time points during
the scattering process, GalNAc-T2 resided predominantly
in stacked cisternae of normal number and length, albeit
sometimes curved in morphology. In favorable sections,
the Golgi stacks were observed in close association with
budding ER regions (ER exit sites). Introduction of
Sar1p
 
dn
 
 in the presence of protein synthesis inhibitors re-
sulted in the slow disappearance of juxtanuclear GalNAc-
T2 and GalT localization with a corresponding ER accu-
mulation. Thus, the predictions of our four tests were met.
We conclude from these results that there exist an ongoing
recycling of Golgi proteins through ER and that this is a
significant pathway in vivo. Moreover, we suggest it is this
process that underlies the abrupt formation of Golgi
stacks at peripheral sites in nocodazole-treated cells.
 
1. 
 
Abbreviations used in this paper:
 
 CHX, cycloheximide; FRAP, fluores-
cence recovery after photobleaching over a narrow area; FRAP-W, fluo-
rescence recover after photobleaching over a wide area; GalNAc-T2,
 
N
 
-acetylgalactosaminyltransferase-2; GalT, 
 
b
 
1,4-galactosyltransferase;
GFP, green fluorescent protein; PDI, protein disulfide isomerase; VSV-G,
vesicular stomatitis virus G protein. 
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Materials and Methods
 
Preparation of Plasmids Coding for Recombinant GFP 
Fusion Proteins or Sar1pH79G
 
GalTÐGFP and GalNAc-T2ÐGFP were constructed by fusing the stalk re-
gion of either GalT or GalNAc-T2 to the NH
 
2
 
 terminus of GFP. DNA
fragments encoding the cytoplasmic, transmembrane, and stalk regions
were generated by PCR with an EcoRI site and a consensus Kozak se-
quence at the 5
 
9
 
 end and a BamHI site at the 3
 
9
 
 end. The primers used for
GalT were 5
 
9
 
 GAA TTC GAA TTC GCC ATG AGG CTT CGG GAG
CCG CT 3
 
9
 
 (forward primer) and 5
 
9
 
 GGA TCC GGA TCC CGG GGC
ACT GGG ACC GAG GTC AA 3
 
9
 
 (reverse primer) to amplify a 361-bp
fragment from the full-length GalT cDNA (sequence data available from
GenBank/EMBL/DDBJ under accession number X55415) corresponding
to amino acids 1Ð120 of the GalT protein. The primers used for GalNAc-
T2 were 5
 
9
 
 GAA TCC GAA TCC GCC ATG CGG CGG CGC TCG
CGG ATG 3
 
9
 
 (forward primer) and 5
 
9
 
 GGA TCC GGA TCC CGA AGC
TTA TCA CTC TCC AC 3
 
9
 
 (reverse primer) to amplify a 338-bp frag-
ment from the full-length GalNAc-T2 cDNA (accession number X85019)
corresponding to amino acids 1Ð114 of the GalNAc-T2 protein. The PCR
fragments encoding the cytoplasmic, transmembrane, and stalk regions
were digested with EcoRI and BamHI and ligated into EcoRI-BamHIÐ
digested pEGFP-N1 from CLONTECH Laboratories (Palo Alto, CA; ac-
cession number U55762) to generate pGalNAc-T2ÐGFP and pGalTÐGFP.
Inserts were checked by sequencing both strands twice using flanking
primers.
The pET-11 plasmid encoding Sar1pH79G (Sar1p
 
dn
 
) was a generous
gift from Dr. W.E. Balch (Scripps Research Institute, La Jolla, CA) and
encodes an NH
 
2
 
-terminally His-tagged, GTP-bound mutant of Sar1a from
CHO (Aridor et al., 1995). For expression in mammalian cells, the pET-11
encoding Sar1p
 
dn
 
 was digested with NdeI immediately before the start
codon. A self complementary synthetic oligonucleotide, 5
 
9
 
 TAGCGG-
GATCCAGATCTGGATCCCGC 3
 
9
 
, encoding a BamHI site and a
Kozak consensus sequence was then inserted. The resulting construct was
then sequenced, and the Sar1p
 
dn
 
 insert was then excised and inserted into
pCMUIV (pSar1p
 
dn
 
CMUIV) (Nilsson et al., 1989) for transient expres-
sion in HeLa cells upon microinjection.
 
Cell Culture, Transfection, and Nocodazole Treatment
 
Monolayer HeLa cells (No. CCL 185; American Type Culture Collection,
Rockville, MD) were routinely cultured in DME supplemented with 10%
fetal calf serum, penicillin (100 U/ml), and streptomycin (100 
 
m
 
g/ml). For
generation of stable transfectants, plasmids encoding GalNAc-T2ÐGFP or
GalTÐGFP were transfected into HeLa cells cultured in 10-cm tissue cul-
ture dishes in the presence of 5% fetal calf serum using the calcium phos-
phate protocol as described (Pbo et al., 1986). Selection was for 
 
z
 
3 wk
in the above medium supplemented with Geneticin (G-418 sulfate, 400
 
m
 
g/ml). After significant cell death had occurred and cells began to grow
robustly in the presence of Geneticin, cells positive for GFP fluorescence
were sorted by a fluorescence-activated cell sorter (FACS
 
¨ 
 
[Becton Dick-
inson, Sparks, MD], fluorescein filter set, excitation with 488 Argon-ion
laser line). The GFP-positive cells were recultured to expand the cell pop-
ulation. Cells were re-sorted as needed to maintain the purity of the popu-
lation.
In most experiments, cells were exposed to nocodazole at a concentra-
tion of 10 or 20 
 
m
 
M with no prior cold pretreatment (Yang and Storrie,
1998). Control experiments established that 10 and 20 
 
m
 
M nocodazole
gave identical effects. Nocodazole perfusion experiments were performed
in a FCS2 chamber (Bioptechs, Butler, PA; http://www.bioptechs.com)
mounted on the microscope stage. GalNAc-T2ÐGFP or GalTÐGFP HeLa
cells were grown on 40-mm coverslips and pretreated with 100 
 
m
 
g/ml cy-
cloheximide for at least 15 min. A prenocodazole image was then ac-
quired, and nocodazole at 20 
 
m
 
M plus cycloheximide at 100 
 
m
 
g/ml in com-
plete DME medium was gravity-perfused into the chamber. Perfusion
time was typically less than 60 s. The image was refocused and the time se-
ries started. For fluorescence recovery after photobleaching over narrow
(FRAP) or wide area (FRAP-W) experiments, GalNAc-T2ÐGFP or
GalTÐGFP HeLa cells grown on 15-mm coverslips were chilled on ice for
10 min and then warmed to 37
 
8
 
C in the presence of 20 
 
m
 
M nocodazole.
Cells were incubated at 37
 
8
 
C in a CO
 
2
 
 incubator for at least 6 h to scatter
the Golgi completely. The coverslip cultures were then transferred to
complete medium containing 20 
 
m
 
M nocodazole plus 100 
 
m
 
g/ml cyclohex-
 
imide and mounted at 37
 
8
 
C in a small aluminum slide chamber (Parton
et al., 1992).
 
Microinjection of pSar1p
 
dn
 
CMUIV and Sar1p
 
dn
 
Purified plasmid was microinjected into cell nuclei using either an Eppen-
dorf microinjection system (Hamburg, Germany) or a Zeiss automated in-
jection system (AIS; Carl Zeiss, Jena, Germany). The plasmid concentra-
tion was 140 ng/
 
m
 
l. The coinjection marker was Cascade blue bovine
serum albumin (Molecular Probes, Eugene, OR) at a concentration of
3.33 mg/ml. In some cases, the microinjections were done in either the
presence of nocodazole (10 
 
m
 
M) to depolymerize microtubules and/or cy-
cloheximide (100 
 
m
 
g/ml) or emetine (5 
 
m
 
g/ml) (Sigma, Deisenhofen, Ger-
many) to inhibit protein synthesis. Sar1p
 
dn
 
 was purified essentially as de-
scribed by Rowe and Balch (1995). The protein at a concentration of 1.5
mg/ml was microinjected directly into the cytoplasm of HeLa cells. The
coinjection marker was Cascade blue bovine serum albumin. Injections
were carried out in the presence of 5 
 
m
 
g/ml emetine, and the cells were in-
cubated after injection in the continued presence of emetine.
 
Antibodies
 
Affinity-purified rabbit polyclonal antibodies directed against the VSV-G
epitope (CPYTDIEMNRLGK; Kreis, 1986) have been described previ-
ously (Rttger et al., 1998). Rabbit N10 polyclonal antibodies recognizing
human GalT polypeptide have also been described previously (Watzele
et al., 1991). Affinity-purified rabbit polyclonal antibodies recognizing
GFP were a gift from Dr. Ken Sawin (Cell Cycle Laboratory, Imperial
Cancer Research Fund, London, UK) and have been described previously
(Shima et al., 1997). Mouse monoclonal antibody 1D3 directed against
protein disulfide isomerase (PDI) was a gift from Dr. Stephen Fuller
(European Molecular Biology Laboratory [EMBL-Heidelberg]). Mouse
monoclonal antibody GTL2 directed against GalT was prepared by T.
Suganuma. Cy3-conjugated donkey antiÐrabbit or Ðmouse IgG antibodies
were obtained from Jackson ImmunoResearch Laboratories (West Grove,
PA). Gold-conjugated goat antiÐrabbit secondary antibodies were from
British BioCell (Cardiff, UK).
 
Conventional and Live Cell Confocal
Fluorescence Microscopy
 
For conventional fluorescence microscopy, cells cultured on coverslips
were fixed either with 
 
2
 
20
 
8
 
C methanol (Ho et al., 1989, 1990), or in the
case of microinjected cells, with 3% formaldehyde in PBS. Formaldehyde-
fixed cells were permeabilized with 0.5% Triton X-100 in PBS. Immunola-
beling, observation with either Zeiss IM-35 or Zeiss Axiovert TV100 mi-
croscopes, and photography with either a Photometrics (Tucson, AZ)
SenSys charge-coupled device (CCD) camera or a Hamamatsu 3-chip
color CCD camera (Open Lab, Improvision, Coventry, UK) were as de-
scribed (Yang and Storrie, 1998). Optimal visualization of GalNAc-T2Ð
VSV distribution in the ER of microinjected cells with the Hamamatsu
3-chip CCD camera (8-bit intensity range per chip) frequently required
overexposure of the fluorescence intensity present in juxtanuclear Golgi
of noninjected cells.
For live cell microscopy, cells were viewed with either a Zeiss Axiovert
TV100 microscope or an EMBL-Heidelberg confocal modified Zeiss Ax-
ioplan microscope. Cells were maintained on the microscope stage at 37
 
8
 
C
in an FCS2 chamber or in a small aluminum slide chamber in complete
DME medium that had been preequilibrated in a CO
 
2
 
 incubator. The
small chamber was heated by conduction through the immersion oil from
a heated objective. This maintains the cells under immediate observation
at 37
 
8
 
C. Conventional fluorescence images were acquired with a Hama-
matsu high-speed CCD camera at 50-ms time resolution (Open Lab; Im-
provision, Coventry, UK). All confocal images were acquired on the
Compact Confocal Camera (CCC) built at EMBL-Heidelberg, using a
488-nm argon-ion laser line for GFP excitation, a NT80/20/543 beamsplit-
ter and a 505 longpass emission filter, with a 63
 
3
 
 1.4 NA Planapochromat
III DIC objective (Carl Zeiss). Typically, a single, unaveraged confocal
slice (pinhole 40Ð50 
 
m
 
m) was taken at each time point with a 20Ð40-
 
m
 
s in-
tegration time per pixel. One image frame was typically collected every 10
or 20 s. Over a series of experiments, illumination was varied so that the
images were either unsaturated or brighter structures were saturated in
order to visualize dimmer structures. To increase the depth of field, the
pinhole was opened completely. In FRAP/FRAP-W experiments, a pre-
bleach image was acquired, and then a rectangular area was bleached with 
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high-power (953.39 
 
m
 
W) laser light for 20Ð100 scans at 
 
z
 
1 s per scan. Re-
covery sequences were imaged identically to the nocodazole perfusion ex-
periments. FRAP/FRAP-W experiments were repeated several times with
different sized bleach areas.
 
Image Processing, Analysis of Fluorescence Intensity, 
and Calculation of Apparent Rate Constant
 
All fluorescence image processing was done with Power Macintosh com-
puters using the public domain software NIH Image v1.62b18 (developed
at the U.S. National Institutes of Health and available on the Internet at
http://rsb.info.nih.gov/nih-image) and the Open Lab System 2.0 (Improvi-
sion). Animations of time series were analyzed either with or without 2 or
3 frame running averaging. Images were often displayed using log-up or
 
g
 
-corrected lookup tables to emphasize dim structures. Analysis of aver-
age fluorescence intensity per structure in time-lapse microscopy of no-
codazole-treated GalNAc-T2ÐGFP cells were as previously described
(Presley et al., 1997). In brief, full time-lapse image sets were displayed,
and structures were tracked from individual time frame to frame at 2
 
3
 
screen Òblow-upÓ with the magnification tool and circled, and the measure
function of the analyze menu was used for fluorescence quantification.
The measure function calculates an average intensity per pixel within the
circled area. Fluorescence recovery in small area photobleaching experi-
ments was quantified by averaging the fluorescence per structure over the
entire population of five to six structures included within the inscribed
rectangle. An apparent rate constant for recovery based on diffusion
theory was calculated using the radius of the circle enclosed within the
square bleach area and equations developed by Axelrod et al. (1976). Mi-
crographs were arranged for figures with Adobe Photoshop 4.0.1 (San
Jose, CA).
 
Immunoelectron Microscopy
 
HeLa cells were fixed for 3 h in 2% paraformaldehyde and 0.2% glutaral-
dehyde in 0.2 M sodium phosphate buffer, pH 7.4, and embedded in 10%
gelatin in PBS. Sample preparation, ultrathin sectioning, and immunola-
beling were performed as described previously (Nilsson et al., 1993). For
single-labeling, sections of HeLa cells expressing GalNAc-T2ÐVSV or
GalNAc-T2ÐGFP were incubated with affinity-purified polyclonal anti-
bodies detecting the tag sequence. For double-labelings with two poly-
clonal antibodies, sections were fixed after the first labeling in 2%
paraformaldehyde and 0.2% glutaraldehyde for 10 min and the labeling
procedure was repeated with a rabbit polyclonal antibody recognizing
endogenous GalT. For double-labelings with one monoclonal and one
polyclonal antibody, sections were incubated simultaneously with both
primary antibodies, followed by two separate incubations with the appro-
priate gold-conjugated secondary antibodies. Antibody dilutions were
1:100 to 1:200 for antiÐVSV, 1:50 for anti-GalT (N10), 1:10 for anti-PDI,
and 1:100 for all gold-conjugated goat antiÐrabbit secondary antibodies
(British BioCell). After immunolabeling, sections were positively stained
and embedded with 2% methyl cellulose containing 0.3% uranyl acetate
(Tokuyasu, 1978), air-dried, and viewed in a Zeiss EM10 at 80 kV.
 
Quantification of Electron Micrographs
 
The labeling densities of expressed GalNAc-T2 (10 nm gold) over Golgi
stacks, nonstacked Golgi associated membrane profiles, ER, and mito-
chondria were determined by the point-hit method (Weibel, 1979). Gal-
NAc-T2ÐVSVÐpositive areas were photographed at random, at 34,000
magnification, and negatives scanned using a flat-bed scanner (model
Scanmaker III; Mikrotek Lab, Inc., Santa Clara, CA) and printed at a fi-
nal magnification of 74,000. 15 images were analyzed per each test condi-
tion. Golgi stacks were defined as membrane structures containing three
or more cisternae that overlap within half or more of their median cister-
nal length. Nonstacked Golgi-associated membrane profiles (Golgi tu-
bules) were defined as tubularÐvesicular structures adjacent to Golgi
stacks. A square-lattice grid with a spacing 
 
d
 
 
 
5 
 
17 mm was used to count
the points
 
 P 
 
corresponding to the grid line intersections with the mem-
branes of the respective structure. Labeling densities were calculated by
dividing the number of 10-nm gold particles (GalNAc-T2ÐVSV) that fall
into the boundaries of each type of structure by the product of the number
of points of intersection of the structure
 
 P 
 
with the grid multiplied by 
 
d
 
2
 
.
Background labeling was calculated by counting the number of gold parti-
cles detected over mitochondria. It was usually less than 2 gold particles/
 
m
 
m
 
2
 
. Standard errors of the mean were calculated.
To evaluate Golgi stack length for linear and curved Golgi onions,
lengths were traced on printed micrographs and converted to microme-
ters. The length of Golgi ribbons were traced with the map tool; a Golgi
ribbon is defined as a continuous GalNAc-T2ÐVSV labeling pattern with
no gaps of more than 0.2 
 
m
 
m. The number of cisternae per Golgi stack, be
it linear or curved into an onion structure, were counted by direct inspec-
tion of prints. Mean lengths and cisternal numbers were counted for each
time of nocodazole treatment, and the standard error of the mean was cal-
culated. Control histograms of length distributions and cisternal number
indicate that the mean values are a fair comparative parameter. Micro-
graph sets were assembled into figures using Adobe Photoshop 4.0.1 soft-
ware.
 
Results
 
Localization of GalNAc-T2ÐGFP and ÐVSV in 
Untreated and Nocodazole-treated Cells
 
To address how peripheral Golgi elements form upon mi-
crotubule depolymerization, we visualized the scattering
process directly in living cells and morphometrically char-
acterized the ultrastructural products of Golgi scattering.
As Golgi markers, we chose GalNAc-T2 and GalT. Both
glycosyltransferases are type II transmembrane proteins
and localize to the Golgi apparatus with high specificity.
Endogenous GalNAc-T2 is found across the entire Golgi
stack, with a distribution skewed slightly towards the 
 
me-
dial
 
- and 
 
trans
 
-cisternae (Rttger et al., 1998). Endoge-
nous GalT has a more polarized distribution towards the
 
trans
 
-Golgi and TGN (Roth and Berger, 1982; Rttger et al.,
1998). To label the Golgi in living cells, we expressed chi-
meric proteins between GalNAc-T2 or GalT and GFP.
The respective glycosyltransferase stalk region, sufficient
for Golgi localization (for review see Fllekrug and Nils-
son, 1998), was fused to the NH
 
2
 
 terminus of GFP, thus
substituting GFP for the lumenal, catalytic domain of the
enzyme. We then generated stable HeLa cell lines express-
ing either GalNAc-T2ÐGFP or GalTÐGFP. Similar GFP
fusion proteins have been shown by others to localize
properly to the Golgi apparatus (Sciaky et al., 1997; Shima
et al., 1997). We show here (confocal microscopy, Fig. 1 
 
A
 
)
that GalNAc-T2ÐGFP distributed in live cells in a compact
juxtanuclear pattern very similar to that of endogenous or
epitope-tagged GalNAc-T2 (Rttger et al., 1998). At the
ultrastructural level, immunogold labeling of thawed cryo-
sections showed GalNAc-T2ÐGFP associated with Golgi
stacks (Fig. 1 
 
B
 
, 
 
arrowhead
 
) and tubulovesicular elements
adjacent to Golgi stacks (Fig. 1 
 
B
 
, 
 
asterisk
 
). Similarly,
we observed a Golgi-specific localization for GalTÐGFP
consistent with its endogenous distribution (results not
shown). GalNAc-T2ÐGFP and GalTÐGFP are thus bona
fide markers for the Golgi and Golgi-derived structures in
living cells.
To morphometrically characterize Golgi scattering at
the ultrastructural level, we immunolabeled GalNAc-T2
tagged with the VSV-G epitope (GalNAc-T2ÐVSV) in
thawed cryosections. Because the GalNAc-T2ÐVSV/anti-
body pairing gives abundant and highly Golgi-specific la-
beling in non-drug treated cells (Rttger et al., 1998), we
were able to identify GalNAc-T2ÐVSVÐpositive structures
regardless of their morphology. Stably expressed GalNAc-
T2ÐVSV has the same quantitative distribution as endoge-
nous GalNAc-T2 but is much easier to detect since it is
more abundant and reacts well with affinity-purified poly-Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1509
clonal antiÐVSV-G (Rttger et al., 1998). The time course
of nocodazole-induced Golgi scattering in HeLa cells ex-
pressing GalNAc-T2ÐVSV was established by immunoflu-
orescence with the same antiÐVSV-G antibody used for
our ultrastructural analysis. In agreement with previous
studies (Yang and Storrie, 1998), Golgi scattering in HeLa
cells was a gradual process, not quite complete at 4 h; full
dispersal to peripheral structures was apparent after a 6-h
or longer incubation with nocodazole (Fig. 2). Projections
of confocal serial sections showed that the fluorescent
Golgi markers scattered over the entire volume of the
cell excluding the nucleus (data not shown). Nocodazole-
induced Golgi scattering did not depend on new protein
synthesis. Treatment of cells with cycloheximide at 100
mg/ml before and during nocodazole treatment had no ef-
fect on the scattering process for any of the markers (data
not shown; Turner and Tartakoff, 1989; Cole et al., 1996a;
Yang and Storrie, 1998). Thus, existing Golgi-resident
transmembrane proteins, including our markers, must
somehow migrate or redistribute to generate the periph-
eral structures.
Peripheral Golgi Structures Appear in an
Episodic Manner
We monitored the initial stages of Golgi scattering in live
HeLa cells stably expressing GalNAc-T2ÐGFP or GalTÐ
GFP. Cells were perfused with 20 mM nocodazole in the
presence of cycloheximide directly on the confocal micro-
scope stage and then observed over time. Experiments
were repeated multiple times, varying nocodazole expo-
sure time, illumination intensity, optics (confocal versus
conventional optics), and in some cases pretreating the
cells with nocodazole on ice. Similar results were seen un-
Figure 1. GalNAc-T2ÐGFP accurately marks the Golgi in vivo.
GalNAc-T2ÐGFP was stably expressed in HeLa cells as described
in Materials and Methods. (A) GalNAc-T2ÐGFP in live HeLa
cells, confocal microscope image. The fluorescence patterns in
the five cells shown are juxtanuclear and in some cases encircle
the nucleus. The cells shown have a typical Golgi distribution.
(B) GalNAc-T2ÐGFP associates with Golgi stacks and tubulove-
sicular elements in cryo-EM sections. GalNAc-T2ÐGFP is re-
vealed by immunogold labeling (10-nm particle size) with a pri-
mary antibody directed against GFP. The gold particles are
associated with stacked and tubulovesicular elements of a long
Golgi ribbon. The black arrowhead points to an example where
the section passes perpendicular to a Golgi stack. The asterisk in-
dicates a tubulovesicular region within the Golgi ribbon. Bar in
A, 20 mm.
Figure 2. Long-term scattering kinetics of GalNAc-T2 in re-
sponse to nocodazole-induced microtubule depolymerization.
HeLa cells stably transfected with GalNAc-T2ÐVSV were incu-
bated with nocodazole for the times indicated in the figure. Cov-
erslip cultures were fixed with methanol and then processed for
immunofluorescence using affinity-purified rabbit antiÐVSV anti-
bodies and Cy3-conjugated antiÐrabbit secondary antibodies.
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der all conditions, including conventional rather than con-
focal optics, where the depth of imaging field was much
greater. Golgi scattering was followed for 1Ð2 h after no-
codazole addition. This is the key time period of initial ap-
pearance of many individual peripheral Golgi elements.
Because of technical limitations in maintaining focal plane,
we were unable to follow in living cells the complete kinet-
ics of Golgi scattering over its full 4Ð6 h time course.
Fig. 3 shows a representative experiment with cells ex-
pressing GalNAc-T2ÐGFP. Single unaveraged confocal
scans were collected every 10 s for 1 h after addition of no-
codazole. Early after nocodazole addition, the Golgi was a
compact structure localized next to the nucleus, occasion-
ally with a few separate elements immediately adjacent
(Fig. 3 A). Readily apparent peripheral elements first ap-
peared after z5Ð10 min and increased in number over the
1-h time span of the experiment (Fig. 3, compare A with
K), although concentrated juxtanuclear fluorescence re-
mained. Animation of the time series showed that individ-
ual peripheral elements appeared faintly yet abruptly at a
remote site, increased in fluorescent intensity at that site,
and then remained stable in both intensity and position.
Very rarely did peripheral Golgi elements move over dis-
tances of more than 1 mm, and directed movement could
not be discerned. To show such movement information in
a single image, we averaged images over z8-min time
spans from four different periods, hence sampling the en-
tire time course. Fig. 3 shows three images for each of four
Figure 3. With nocodazole
addition, GalNAc-T2ÐGFP
appears at scattered sites
with no net outward move-
ment in live cells. HeLa cells
stably expressing GalNAc-
T2ÐGFP were incubated with
20  mM nocodazole for the
times indicated. Six cells are
shown. Unaveraged confocal
scans were taken every 10 s
for 1 h after nocodazole addi-
tion. Four different periods
spanning the time course are
shown (AÐC, DÐF, GÐI, and
JÐL). The images in the first
column (A, D, G, and J) are
the first time point in the pe-
riod, the images in the second
column (B, E, H, and K) are
the last time point in the pe-
riod, and the images in the
third column (C, F, I, and L)
are an average of all time
points from the first through
the last in the period, inclu-
sive. Peripheral fluorescent
patches appear faintly, accu-
mulate fluorescence, and then
remain stable in intensity and
position. The net number of
peripheral patches in a cell in-
creases gradually with time.
The averaged frames (C, F, I,
and  L) reveal no net direc-
tional movement of fluores-
cent patches. Bar, 20 mm.Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1511
periods. The first time point in the period is in the left col-
umn (A, D, G, and J), the last time point is in the middle
column (B, E, H, and K), and the average of all images in-
cluded within each time period is in the right column. In
such averaged images, movement of an element over time
would produce an elongated smear or a track to nearly
continuous trail of fluorescent structures depending on
rate of movement, because the element is in a different po-
sition in each frame being averaged. We see little such
smearing or elongation in the averaged images. Rather,
the area that a peripheral Golgi element occupied within a
given period showed as a slightly enlarged region of fluo-
rescence relative to a single time frame, indicating that the
element moved within a small domain. We examined more
closely the appearance of individual elements in a single
cell. In Fig. 4, the three elements a, b, and c in H first ap-
peared faintly (B) at sites near the cell periphery, and then
became gradually brighter (compare BÐD). Four-frame
averages covering the time points in AÐD showed that the
three elements do not change position from frame to
frame. Similar results were seen with GalTÐGFP, although
GalTÐGFP scattered somewhat more rapidly (data not
shown).
To quantify the kinetics of formation of individual pe-
ripheral Golgi elements and their stability once formed,
we scored the fluorescent intensity of 15 individual peri-
pheral fluorescent elements over time. All 15 individual
elements increased linearly in fluorescence intensity for
about 2 min, the abrupt formation period, and then were
fairly stable in fluorescence over an extended period of
time (data not shown). The fluorescence intensity of in-
dividual structures was z3.5Ð5-fold greater than back-
ground. In a further effort to detect intermediates or out-
ward tracking of individual Golgi elements from the
juxtanuclear region, similar nocodazole scattering periods
were examined at near video rates (20 frames per second)
with a high-speed CCD camera and conventional optics.
Again appearance at peripheral sites was abrupt and epi-
sodic; no outward movements from the juxtanuclear re-
gion were observed, and no vesicular intermediates were
detected. Thus, time-lapse observation, be it with confocal
or conventional optics of GalNAc-T2ÐGFP and GalTÐ
GFP in live cells, shows that during microtubule depoly-
merization, peripheral Golgi elements arise abruptly, ap-
parently de novo. Once they appear, peripheral Golgi
fragments do not move directionally and increase in fluo-
rescence intensity briefly, accumulating GalNAc-T2ÐGFP
or GalTÐGFP, and then become relatively stable. These
results are completely consistent with the proposed hy-
pothesis that peripheral Golgi fragments arise due to slow,
constitutive cycling of Golgi components followed by
abrupt coalescence of these components at or about ER
exit sites (Cole et al., 1996a; Yang and Storrie, 1998).
Scattered Golgi Structures Consist of Stacked Cisternae
To characterize the structure of nocodazole-scattered,
Golgi-derived elements and possible intermediates in their
formation, over the full time course of nocodazole-induced
Golgi scattering, we fixed HeLa cells stably expressing
GalNAc-T2ÐVSV at 0, 1, 2, 4, and 7.5 h after nocodazole
addition and processed them for immunoelectron micros-
copy with the same anti-VSV antibody used for immuno-
fluorescence experiments. Thawed cryosections were dou-
ble-labeled with 10-nm gold for the VSV epitope and 5-nm
gold for endogenous PDI, an ER marker. We photo-
graphed 15 GalNAc-T2ÐVSVÐpositive fields at random
and scored them morphometrically. Initially (0 time), Gal-
NAc-T2ÐVSV immunogold labeling was restricted almost
exclusively to long, juxtanuclear Golgi ribbons consisting
of a mix of stacks and interconnecting tubulovesicular
structures (Fig. 5 A, 10-nm gold). The essentially continu-
ous ribbons of GalNAc-T2ÐVSV labeling were frequently
interrupted by gaps in the labeling continuity such as that
shown in Fig. 5 A (white arrow). Only rarely did PDI label
Figure 4. Formation of individual peripheral patches induced by
nocodazole treatment. A brief, early time interval was selected
from the time-lapse experiment shown in Fig. 3. The abrupt ap-
pearance of three peripheral fluorescent patches (marked as aÐc,
in H) is shown over a 2.5-min period. AÐD are individual confo-
cal frames at the indicated time points after nocodazole addition.
EÐH are frame averages over the indicated time intervals in sec-
onds. The circled areas in A (aÐc) will be sites of subsequent fluo-
rescent patch formation. Individual patches appear abruptly
(compare  A and B). At first they appear faint (B), but they then
accumulate fluorescence (compare BÐD). The averaged frames
indicate no net outward directional movement of individual
patches from the cell center, although they do oscillate within a
small area defined by the smeared regions in the averaged panels
(FÐH). Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 1512
(5-nm gold, Fig. 5 A, black arrowhead) intermix with Gal-
NAc-T2ÐVSV. A small amount of PDI was found in the
cis-Golgi network and in the cis-cisternae. After 2 h of no-
codazole treatment, GalNAc-T2ÐVSV was occasionally
found in stacked structures that curved back on them-
selves, which we refer to as onions (Fig. 5 B,  asterisk);
more frequently, GalNAc-T2ÐVSV associated with flat-
tened stacks and tubulovesicular structures (Fig. 5 B, ar-
row). After longer nocodazole treatment (4 and 7.5 h), the
onion structures became more common (Fig. 5 C, aster-
isks). At 7.5 h, onions accounted for z40% of the stacked
Golgi profiles. The onion structures were polarized as in-
dicated by labeling for endogenous GalT, a well-character-
ized  trans-Golgi/TGN marker (Roth and Berger, 1982;
Rttger et al., 1998), as were the flattened scattered Golgi
stacks (Fig. 6). In favorable sections, GalNAc-T2ÐVSVÐ
positive, scattered Golgi stacks in nocodazole-treated cells
appeared to be associated with ER exit sites (data not
shown).
Quantitatively, the length of Golgi ribbons, defined as
continuous gold-labeled structures with no gaps in label-
ing, dropped upon nocodazole treatment (Fig. 7 A), con-
sistent with previous studies (for review see Burkhardt,
1998). However, over the entire 7.5-h nocodazole expo-
sure, the average length of individual stack units and the
number of cisternae per stack stayed rather constant (Fig.
7 A). There was a transient decrease in GalNAc-T2ÐVSV
labeling density (gold particles per mm2) over Golgi-like
stacks and tubules (Fig. 7 B). At all time points, the den-
sity of GalNAc-T2ÐVSV labeling over the ER was low,
z50Ð60-fold less than that over Golgi stacks or tubules,
and increased only slightly during Golgi scattering (Fig. 7
B). In conclusion, our ultrastructural observations show
that the bulk of GalNAc-T2ÐVSV is present in individual
Golgi-like structures, cisternal stacks (flattened and onion-
like), and associated tubules during the entire period of
nocodazole treatment. Since our time-lapse observations
of GalNAc-T2Ð and GalTÐGFP in live cells showed that
intact stack fragments do not track outward, we suggest
that individual Golgi stacks must form de novo at periph-
eral sites. Additionally, the frequency of Golgi onions in-
creased only after a time lag following nocodazole addi-
Figure 5. Immunogold local-
ization of GalNAc-T2ÐVSV
shows that the Golgi main-
tains its stack structure upon
nocodazole treatment. HeLa
cells stably transfected with
GalNAc-T2ÐVSV were ei-
ther fixed immediately (A)
or incubated in the presence
of nocodazole for 2 h (B) or
7.5 h (C). Cryosections were
double labeled for GalNAc-
T2ÐVSV (Golgi, 10-nm
gold) and PDI (ER, 5-nm
gold). As can be seen in A,
GalNAc-T2ÐVSV enriched
structures in control cells
consist of a mix of stacked
Golgi cisternae and tubu-
lovesicular structures. Con-
tinuous segments of stacked
cisternae and tubulovesicular
structures are termed a Golgi
ribbon. The white arrow
points to an example of an
interruption that divides an
otherwise continuous Golgi
ribbon into two segments.
The black arrowhead points
to PDI in an ER element. In
nocodazole-treated cells (B
and  C), GalNAc-T2ÐVSVÐ
enriched structures consist
either of linear stacks of
Golgi cisternae (B,  white
arrowhead) and associated
tubulovesicular structures or
stacks and associated tubu-
lovesicular structures that curve
back on themselves to form
onions (asterisks, B and C).Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1513
tion, suggesting that these structures are newly formed,
rather than being rearrangements of preexisting Golgi
stacks. As we never observed major concentrations of Gal-
NAc-T2ÐVSV in intermediate structures, individual pe-
ripheral Golgi stacks must form and concentrate GalNAc-
T2ÐVSV quickly, in agreement with our observation in
live cells that peripheral structures appeared abruptly and
then accumulated Golgi-resident proteins rapidly over a
very brief time window. These observations are consistent
with the proposed hypothesis that cycling Golgi proteins
may coalesce at or about ER exit sites to regenerate Golgi
stacks de novo.
Peripheral Golgi Stacks Slowly Exchange
Resident Proteins
If Golgi proteins are indeed recycling, then peripheral
Golgi stacks may be continuously exchanging resident
proteins with each other. As a first step in characterizing
whether or not such exchange does occur, we took a pho-
tobleaching approach using cells expressing GalNAc-T2Ð
GFP or GalTÐGFP. To produce peripheral Golgi stacks,
cells were pretreated with nocodazole. We then pho-
tobleached GFP fluorescence associated with a subset of
these structures. In all experiments, we preincubated cells
with 100 mg/ml of cycloheximide for at least 15 min before
the bleach and continuously after the bleach, so any recov-
ery must be due to transfer from nonbleached Golgi ele-
ments. We repeated the experiments several times, vary-
ing the size of the bleached area. When only a small area
of the cell was bleached, 5% or less, recovery of fluores-
cence over the bleached area should be accompanied by
no detectable loss of fluorescence over the remainder of
the cell. This approach is termed FRAP for fluorescence
recovery after photobleaching. From the rate of recovery,
an apparent rate constant can be calculated. This is equiv-
alent to an apparent diffusion coefficient. When a large
area of the cell was bleached, z50%, recovery of fluores-
cence over the bleached area could only occur with signifi-
cant loss of fluorescence from the remainder of the cell.
This approach is termed FRAP-W for fluorescence recov-
Figure 6. Peripheral Golgi
structures are polarized. Both
linear (A) and onion-shaped
Golgi stacks (B) in nocoda-
zole-treated cells show a po-
larized distribution of GalT.
HeLa cells stably expressing
GalNAc-T2ÐVSV were in-
cubated with nocodazole for
7.5 h. Cells were then fixed
and processed for cryosec-
tioning and immunolabeling
with 15-nm gold (GalNAc-
T2ÐVSV) and endogenous
GalT (5-nm gold). The black arrowheads point to examples of GalT (5-nm gold) labeling to one side of the Golgi stack. In sections cut
perpendicular to Golgi stacks, GalNAc-T2ÐVSV distributes across much of the stack while GalT is found predominantly to one side.
Figure 7. Stacks are maintained, and GalNAc-T2ÐVSV labeling
remains concentrated in cisternae as the Golgi scatters. 15 differ-
ent images were quantified for each time point. The number of
cisternae per stack includes both flattened and curved stacks (A).
Golgi ribbon length decreases slightly (see Figs. 1 and 5 for visual
examples of Golgi ribbons), and stack length actually increases
(A). GalNAc-T2ÐVSV labeling distribution over Golgi-like struc-
tures dropped transiently during Golgi scattering (B). Only a
small increase in GalNAc-T2 labeling density over the ER was
observed consistent with Golgi proteins concentrating during epi-
sodic assembly events into Golgi stacks. Error bars are the stan-
dard error of the mean.The Journal of Cell Biology, Volume 143, 1998 1514
ery after photobleaching over wide area. If all peripheral
Golgi stacks are active in protein exchange, then at the
end of a FRAP-W experiment a reduced level of fluores-
cence should be observed across the entire organelle pop-
ulation.
Photobleaching of a small area, 4 3 4 mm square, was
followed by progressive fluorescence recovery, which was
complete within about 90 min and had a half-time of about
35 min (Fig. 8). Interestingly, recovery occurred at the
same rate across the entire bleached area, regardless of the
distance from the bleach boundary (compare Fig. 8, C and
D). This suggests that the peripheral Golgi stacks were ef-
fectively interconnected by a fast exchange network. One
such example could be the ER. The apparent rate constant
for fluorescence recovery in this representative experi-
ment was 5 3 10212 cm2/s, about 1/2,000th the diffusion
constant reported for Golgi membrane proteins in intra-
cellular membranes (Storrie et al., 1994; Cole et al., 1996b;
Ellenberg et al., 1997). As expected for FRAP experiment,
there was no detectable loss of fluorescence from the non-
bleached areas.
Fig. 9 shows a representative FRAP-W experiment
where the bleached area, 32 3 19 mm, was about half of
the cell area (Fig. 9, A and B, boxed areas). Fluorescence
Figure 8. FRAP experiments reveal that resident Golgi proteins
are exchanged slowly between peripheral Golgi stacks. Two cells
are shown in the center of the field and a portion of a third in the
upper right hand corner. Cells were treated with nocodazole for 6 h
to scatter the Golgi. The boxed 4 3 4 mm area in the upper center
cell was photobleached (B). The cells were observed at 10-s inter-
vals for 90 min after the bleach. As shown in C and D, photore-
covery of the peripheral bleached patches was gradual with
recovery at the same rate across the entire boxed area. Fluo-
rescence recovery is quantified in E as described in Materials
and Methods. Zero time is immediately after the bleach (B). Bar,
5.0 mm. Figure 9. FRAP-W experiments reveal that the entire population
of peripheral Golgi stacks are active in protein exchange. Three
cells are shown. Cells were treated with nocodazole for 6 h to
scatter the Golgi. The boxed area covering cell 1 (A, z50% of
cell area) was photobleached (B). The cells were observed at 10-s
intervals for 2 h after the bleach. As shown in CÐF, photorecov-
ery of the peripheral bleached patches was gradual. Correspond-
ingly, fluorescence was lost from the nonbleached fluorescent
patches. Zero time is immediately after the bleach (B). Bar, 7.5 mm.Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1515
recovery in the bleached area was gradual, and a loss of
fluorescence from the unbleached area accompanied the
recovery within the bleached zone. Recovery for this large
bleach area was fastest close to the bleach boundary; no-
ticeable recovery was seen within about 5 min in periph-
eral Golgi elements closest to the bleach boundary (Fig.
9 C). At longer times (12Ð25 min, Fig. 9, D and E), fluo-
rescence recovery spread further away from the bleach
boundary. At the same time, loss of fluorescence from
nearby structures in the nonbleached zone became more
apparent. Approximately 2 h after bleach, peripheral
Golgi elements across cell 1 in Fig. 9 had a fairly uniform,
medium-intensity fluorescence, indicating that essentially
all peripheral Golgi stacks were active in protein exchange
(Fig. 9 F). Animation of recovery sequences for either
FRAP or FRAP-W experiments suggested that fluores-
cence reaccumulated into preexisting structures. Little in
the way of collisions between adjacent Golgi stacks was
apparent. Animation under nonsaturating illumination
conditions revealed no obvious exchange intermediates
moving into the bleached area. In animations, where illu-
mination was very intense (z100-fold higher than for the
recovery sequences), we observed a flickering, lacy fluo-
rescent network interconnecting scattered Golgi elements
(data not shown). Within or in close association with this
network were often seen mobile concentrations of fluores-
cent material. These may be intermediates in exchange.
This network may be ER containing low levels of Gal-
NAc-T2ÐGFP or GalTÐGFP. Similar results were seen for
both GalNAc-T2ÐGFP and GalTÐGFP.
We conclude from these experiments that peripheral
Golgi stacks slowly exchange resident transmembrane
proteins via a dissociative process. The apparent rate con-
stant for fluorescence recovery was slow relative to known
diffusion constants for Golgi membrane proteins in either
Golgi or ER membranes (Storrie et al., 1994; Cole et al.,
1996b; Ellenberg et al., 1997). The flux of fluorescence
into the bleached zone during recovery was low, consistent
with the low level of GalNAc-T2ÐVSV seen in ER mem-
branes during nocodazole-induced Golgi scattering.
Golgi Glycosyltransferases Slowly Cycle to the ER with 
Expression of a Dominant-negative Sar1p
The above results suggest that resident Golgi glycosyl-
transferases, type II transmembrane proteins, normally cy-
cle slowly from the Golgi to the ER and back. In the case
of the nocodazole-treated cell, forward transport and jux-
tanuclear accumulation of these cycling Golgi proteins
is blocked because of microtubule depolymerization. To
provide direct evidence in support of this putative cycling
route, we characterized the effect of a dominant-negative
mutant of Sar1p, Sar1pdn, on the distribution of the Golgi
glycosyltransferases, GalNAc-T2ÐVSV and endogenous
GalT. Sar1p, a small GTPase, is required for the recruit-
ment of COPII components onto the ER for the formation
of export vesicles. Addition of His-tagged Sar1pdn to both
in vitro (Aridor et al., 1995) and in vivo assays (Pepperkok
et al., 1998; Shima et al., 1998) has been shown to block
protein export from the ER. We decided to express
Sar1pdn in HeLa cells as a native protein by microinjecting
the plasmid pSar1pdnCMUIV encoding the native protein
as well as microinjecting a purified His-tagged version of
the Sar1pdn. Cycloheximide (CHX) and emetine (Perlman
and Penman, 1970) were used as inhibitors of protein syn-
thesis to test that any observed ER accumulations were
predominantly of preexisting proteins rather than newly
synthesized proteins.
Figure 10. Microinjection of pSar1pdnCMUIV plasmids resulted
in the gradual loss of juxtanuclear Golgi staining for GalNAc-T2Ð
VSV and a concomitant accumulation in the ER. Cells were mi-
croinjected with plasmid as described in Materials and Methods.
Cascade blue bovine serum albumin was used as a coinjection
marker. Microinjected cells are indicated by arrowheads. Cells
were fixed at various times after injection: A, 1 h; B, 2 h; C, 4 h;
D, 6 h; E, 10 h. After a lag period, as seen in A, where there is lit-
tle if any effect on GalNAc-T2ÐVSV distribution, progressive ac-
cumulation in the ER as marked by a weblike cytoplasmic stain-
ing pattern and rim staining of the nucleus was observed. With
time, most if not all juxtanuclear concentration of GalNAc-T2
staining was lost. In F, cells were microinjected with plasmid in
the presence of 100 mg/ml CHX and then incubated for 10 h in
the presence of drug. CHX gave almost complete inhibition of
GalNAc-T2 redistribution. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 1516
Microinjection of pSar1pdnCMUIV produced after a lag
period of 2Ð3 h, a loss of juxtanuclear Golgi staining for
GalNAc-T2ÐVSV, and appearance of an ER-like staining
pattern marked by distinct rim labeling of the nucleus, a
characteristic trait of ER labeling, and a diffuse network-
like labeling of the cytoplasm (Fig. 10, arrowheads point to
injected cells). The development of an ER staining pat-
tern for GalNAc-T2ÐVSV was complete within 6Ð10 h af-
ter microinjection. The disappearance of a juxtanuclear
Golgi staining and the development of an ER labeling pat-
tern for GalNAc-T2ÐVSV was dependent on synthesis of
Sar1pdn as indicated by CHX inhibition when the plasmid
was injected in the presence of drug and cells subsequently
incubated for 10 h in the continued presence of CHX (Fig.
10 F). A similar disappearance of juxtanuclear Golgi label-
ing was seen when cells microinjected with pSar1pdn
CMUIV were stained for GalT (data not shown). The
kinetics of disappearance appeared similar to that of Gal-
NAc-T2. Because GalT labeling was less bright, the ER
accumulation of GalT was more difficult to detect. The im-
age set presented in Fig. 10 was overexposed with respect
to the juxtanuclear Golgi staining in non-injected cells in
order to emphasize the ER labeling of GalNAc-T2ÐVSV.
The fact that two Golgi glycosyltransferases, one epitope
tagged and introduced into HeLa cells by stable transfec-
tion and the other endogenous, behaved the same upon
Sar1pdn expression suggests that loss of juxtanuclear Golgi
staining reflects a general property of the organelle and its
membrane proteins.
The pronounced ER accumulation of GalNAc-T2ÐVSV
in Sar1pdn-expressing cells is due to both redistribution of
preexisting protein and the accumulation of newly synthe-
sized protein. Three approaches were taken to assess
whether or not the predominant accumulation was of pre-
existing molecules. The first approach was a calculation
based on assessment of the metabolic stability of GalNAc-
T2ÐVSV. In control experiments, no loss of GalNAc-T2Ð
VSV antigenicity was observed after 10 h of incubation of
HeLa cells in the presence of 100 mg/ml CHX, a concen-
tration sufficient to give 90Ð95% inhibition of methionine
incorporation, or 5 mg/ml emetine, a concentration suffi-
cient to give 99% inhibition of methionine incorporation
(data not shown). In these experiments, the same camera
exposures were used for nonÐdrug-treated and drug-
treated cells, and all pixels were within the linear range of
the CCD camera. Hence GalNAc-T2ÐVSV may be consid-
ered to be metabolically stable during the time of our ex-
periments. Considering the 24-h generation time of HeLa
cells, .70% of the GalNAc-T2ÐVSV in cells expressing
Sar1pdn for 10 h should be preexisting protein. This per-
centage is even larger at the 6-h postÐplasmid injection
time point. Hence the majority of ER accumulation re-
flected the redistribution of preexisting GalNAc-T2ÐVSV
from a juxtanuclear Golgi to the ER rather than the accu-
mulation of newly synthesized proteins in the ER. As a
further test that preexisting molecules had redistributed
from a juxtanuclear location, the pSar1pdnCMUIV plas-
mid was pulse expressed in cells. In this experimental pro-
tocol, HeLa cells were microinjected with the plasmid, and
then at either 1 h or 3 h after injection, CHX or emetine
was added to inhibit further protein synthesis. The cells
were then fixed 10 h post-injection and the distribution of
GalNAc-T2ÐVSV assessed. As shown in Fig. 11, expres-
sion of plasmid into protein for periods as short as 1 h was
sufficient to produce ER accumulation of GalNAc-T2Ð
VSV and substantial decrease in juxtanuclear Golgi stain-
ing. 3 h of pulse expression limited by either CHX or
emetine addition was sufficient to give full control disap-
pearance of juxtanuclear Golgi staining. As a final test, pu-
rified His-tagged Sar1pdn was microinjected into cells in
the presence of emetine, and the cells were then incubated
afterwards in the continuous presence of emetine. Cells
were then stained either for GalNAc-T2 or GalT. Immu-
nofluorescence staining for GalNAc-T2ÐVSV showed the
beginnings of a nuclear ER-like rim distribution, 1 h after
injection. At later time points, a disappearance of juxtanu-
clear GalNAc-T2ÐVSV staining was observed with kinet-
ics similar to those of the plasmid expression with accumu-
lation in the ER (Fig. 12, A and C). As shown in Fig. 12, B
and D, juxtanuclear endogenous GalT staining decreased
greatly under these conditions. At 1 h after injection, there
were hints of faint, ER-like GalT rim staining of the nu-
cleus in microinjected cells. We conclude that the ER ac-
Figure 11. Pulse expression of Sar1pdn was sufficient to give Gal-
NAc-T2ÐVSV redistribution to the ER. Cells were microinjected
as described in Materials and Methods and the legend for Fig. 10.
Cells were incubated for various times after injection in the ab-
sence of protein synthesis inhibitor. (A) CHX at a concentration
of 100 mg/ml was added 1 h after plasmid injection. Cells were
then incubated in the presence of drug for an additional 9 h. (B)
CHX was added 3 h after microinjection, and cells were incu-
bated for an additional 7 h. (C) Emetine was added at a concen-
tration of 5 mg/ml, and the cells were then incubated for an addi-
tional 7 h. (D) Cells were incubated in the absence of drug for 10 h
after microinjection. Bar, 10 mm.Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1517
cumulation was indeed of preexisting Golgi proteins redis-
tributed from the juxtanuclear Golgi.
Expression of Sar1pdn Inhibits Formation of Peripheral 
Golgi Stacks
To test whether nocodazole-induced Golgi scattering is in-
deed related to resident Golgi protein cycling to the ER,
we performed two additional experiments. In the first,
cells pretreated with nocodazole to scatter the Golgi were
microinjected with pSar1pdnCMUIV and then assayed for
GalNAc-T2ÐVSV distribution after various plasmid ex-
pression periods in the continued presence of nocodazole.
In the second, microinjected cells preexpressing Sar1pdn
for 3 h were treated with nocodazole to initiate Golgi scat-
tering and assayed for GalNAc-T2ÐVSV distribution. As
shown in Fig. 13 (arrowheads point to injected cells), after
nocodazole pretreatment (here 5 h) GalNAc-T2ÐVSV was
distributed in scattered fluorescent staining structures.
With expression of plasmid after a lag period of about 3 h,
there was a progressive disappearance of most to nearly all
the peripheral Golgi structures and an ER accumulation
of GalNAc-T2. These kinetics were similar, albeit perhaps
slightly slower, than that for disappearance of the juxtanu-
clear Golgi upon plasmid expression. As shown in Fig. 14
(arrowheads point to injected cells) with Sar1pdn pre-
expression, addition of nocodazole for 1 h failed to pro-
duce the relatively extensive initial phase of nocodazole-
induced Golgi scattering seen in adjacent noninjected
cells. In the microinjected cells, ER accumulation of Gal-
NAc-T2 was often apparent as indicated, in particular, by
nuclear rim staining. We conclude from these experiments
that Golgi transmembrane proteins in nocodazole-treated
cells cycle through the ER.
Discussion
The underlying rationale behind these experiments came
from our previously stated hypothesis that Golgi trans-
membrane proteins cycle from the Golgi stack to the ER
and back (Storrie and Yang, 1998; Yang and Storrie,
1998). This hypothesis was prompted by our recent obser-
vations in both Vero and HeLa cells that during microtu-
bule depolymerization, trans-Golgi/TGN type II mem-
brane proteins appeared in peripheral structures more
rapidly than comparable medial/trans-Golgi membrane
proteins (Yang and Storrie, 1998) and in HeLa cells that
disruption of cytoplasmic dynein function resulted in no-
codazole-like Golgi scattering (Burkhardt et al., 1997).
From these data, we hypothesized that there might be
direct trafficking of Golgi proteins to the ER with sub-
sequent juxtanuclear accumulation being blocked at or
about ER exit sites by the nocodazole-induced depolymer-
ization of microtubules (Yang and Storrie, 1998) or inac-
tive motor proteins (Burkhardt et al., 1997). The same hy-
pothesis based on a different set of data from nocodazole
experiments has been proposed by Lippincott-Schwartz
and colleagues (Cole et al., 1996a). In the present work,
Figure 12. Sar1pdn induced ER accumulation of GalNAc-T2Ð
VSV or GalT by Sar1pdn protein injection. Cells were microin-
jected with Sar1pdn protein in the presence of 5 mg emetine and
then incubated for various times (A and B, 1 h; C and D, 10 h) in
the presence of emetine. This concentration of emetine is suffi-
cient to inhibit 99% of cellular protein synthesis. Cascade blue
bovine serum albumin was used as a coinjection marker. Microin-
jected cells are indicated by arrowheads. In A and C, staining is
for GalNAc-T2ÐVSV, and in B and D, staining is for GalT. Bar,
10 mm.
Figure 13. GalNAc-T2ÐVSV associated with nocodazole periph-
eral Golgi stacks redistributed to the ER in cells expressing
Sar1pdn. Cells were preincubated with nocodazole (Noc) for 6 h be-
fore microinjection. Plasmid microinjection was as described in
Materials and Methods. Cascade blue bovine serum albumin was
used as a coinjection marker. Microinjected cells are indicated by
arrowheads. Cells were fixed at various times after injection: B, 2 h;
C, 6 h; D, 10 h. Nuclear rim staining and diffuse staining of weblike
cytoplasmic fluorescence indicate ER localization. Bar, 10 mm.The Journal of Cell Biology, Volume 143, 1998 1518
we have formulated and conducted four different tests of
this hypothesis: (a) Peripheral Golgi structures (stacks)
during microtubule depolymerization should form in an
episodic manner similar to that of the recently reported
formation of ts-GÐGFPÐlabeled vesicularÐtubular struc-
tures at ER exit sites (Presley et al., 1997; Scales et al.,
1997). The postulated block in Golgi protein cycling is at
the level of juxtanuclear collection of Golgi structures and
is post-ER exit. (b) Peripheral Golgi stacks should ex-
change proteins with one another on a time scale of tens of
minutes in a manner suggestive of an ER intermediate in
the exchange process. (c) Expression of Sar1pdn, known to
block ER exit, should lead to ER accumulation of preex-
isting Golgi membrane proteins. (d) Expression of Sar1pdn
should interfere with nocodazole-induced Golgi scattering
and lead to the disappearance of scattered Golgi struc-
tures as the proteins present in these structures accumu-
late in the ER. Here, we find that the outcome of each test
supports our fundamental hypothesis. In stating these pos-
itive conclusions in support of a novel pathway, we would
like to acknowledge that the present experiments are only
a step towards elucidating the nature of this pathway. Fu-
ture experiments will determine to what extent this path-
way recycles Golgi proteins in relation to other possible
recycling pathways.
To test whether or not peripheral Golgi structures
(stacks) appeared in an episodic manner during microtu-
bule depolymerization, we expressed two chimeric pro-
teins, GalNAc-T2ÐGFP and GalTÐGFP, to fluorescently
mark the Golgi in living HeLa cells and used our previous
construct, GalNAc-T2ÐVSV (Rttger et al., 1998), as an
abundant, epitope-tagged analogue for ultrastructural stud-
ies. All three chimeras are from well-characterized, type
II, Golgi-resident, transmembrane proteins. GalNAc-T2
was chosen for most experiments because it provides a
marker for the entire Golgi stack with only limited prefer-
ence for one part of the stack, trans over cis (Rttger et al.,
1998). Microtubule depolymerization was induced by ad-
dition of the drug nocodazole. By correlating GalNAc-T2Ð
GFP fluorescence distribution in living cells and GalNAc-
T2ÐVSV immunogold labeling in thawed cryosections, we
were able to assess the trafficking and organizational state
of the Golgi complex continuously during its scattering in
response to microtubule depolymerization. We found that
individual stacked Golgi elements formed at peripheral
cytoplasmic sites in a burst-like or episodic manner. We
never observed preexisting Golgi elements tracking out-
ward from the juxtanuclear Golgi complex to peripheral
sites. Rather, individual Golgi elements appeared abruptly
at peripheral cytoplasmic sites with no detectable interme-
diates. Once formed, these structures were stable for tens
of minutes, maintaining a fairly constant fluorescence in-
tensity. Superficially at least, this abrupt or episodic ap-
pearance of Golgi elements at peripheral sites in living
cells is exactly analogous to the formation of VSV-GtsÐ
GFPÐlabeled vesicularÐtubular structures at ER exit sites
(Presley et al., 1997; Scales et al., 1997). This is positive ev-
idence for the first test of our hypothesis.
Based on ultrastructural evidence, the newly formed
Golgi elements during microtubule depolymerization must
rapidly assume a stacked morphology; the frequency of
stacked cisternal-like structures positive for GalNAc-T2
was at least as high, if not higher, than in untreated control
cells. Neither the number of cisternae per stack nor the
breath of individual stacked cisternae in cross section de-
creased. Peripheral Golgi stacks were polarized in their
distribution of the trans-Golgi/TGN marker, GalT. What
did change was that Golgi elements were no longer exten-
sively interconnected. The peripheral Golgi stacks were
frequently curved back on themselves in a structure we
term onions. Such structures can be seen at a very low fre-
quency in control cells and resemble intermediates in in
vitro Golgi assembly (Rabouille et al., 1995b). The gradual
accumulation of onion forms at peripheral sites during
Golgi scattering is consistent with these structures being
newly generated and suggests that a normal role of micro-
tubules is to aid in the maintenance of a flattened, ex-
tended Golgi stack morphology. The slow and ultimately
incomplete disappearance of spread, flattened Golgi stacks
during microtubule depolymerization suggests that Golgi
cisternae may well sequester or support the association of
stabilizing molecules for long periods. Also, there may be
some preferential association of residual, stable microtu-
bules with spread individual Golgi stacks that may prevent
the stack from curving back upon itself. Minin (1997) has
suggested that drug-stable microtubules are important in
Golgi scattering. Individual electron micrographs sug-
gested an association between peripheral Golgi stacks and
ER exit sites. In summary, these observations indicate a
coalescence of Golgi proteins at peripheral sites within the
cell to generate stacked Golgi cisternae. This is a process
consistent with blocked juxtanuclear accumulation of cy-
cling of Golgi transmembrane proteins.
To test whether nocodazole-scattered Golgi stacks ex-
change proteins with one another in a manner consistent
with ER cycling, we took a photobleaching approach using
both FRAP and FRAP-W protocols. FRAP experiments
with GalNAc-T2ÐGFP and GalTÐGFP indicated that
Golgi-resident transmembrane proteins slowly cycle over
tens of minutes between peripheral Golgi stacks. Since
new protein synthesis was blocked by cycloheximide, the
fluorescence recovery must be due to protein exchange
between Golgi elements. Photorecovery had an apparent
rate constant of z5 3 10212 cm2/s, about three orders of
magnitude slower than that expected for diffusion for
Figure 14. Expression of
Sar1pdn inhibited nocoda-
zole-induced Golgi scatter-
ing. After microinjection,
cells were incubated for 3 h
before nocodazole addi-
tion. This was to allow for
plasmid expression and ac-
cumulation of Sar1pdn. Plas-
mid microinjection was as
described in Materials and
Methods. Cascade blue bo-
vine serum albumin was
used as a coinjection
marker. Microinjected cells
are indicated by arrowheads. Cells were fixed 1 h after no-
codazole addition. Bar, 10 mm.Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1519
Golgi proteins within a continuous membrane system
(Storrie et al., 1994; Cole et al., 1996b; Ellenberg et al.,
1997; for reviews see Storrie and Kreis, 1996; Lippincott-
Schwartz et al., 1998). In FRAP-W experiments in which
GalNAc-T2ÐGFP or GalTÐGFP fluorescence is photo-
bleached over a large area of the cell and fluorescence loss
over the nonbleached area is monitored as photorecovery
occurs over the bleached area, essentially all peripheral
Golgi stacks within the cell were shown to exchange pro-
teins with one another. Here the total time period for pro-
tein equilibration between the scattered Golgi stacks was
z2 h. The peripheral Golgi structures did not collide with
one another or form tubular interconnections. Imaging at
high intensity illumination revealed movements through
what appeared to be an ER network that were consistent
with the ER being an intermediate in this ongoing Golgi
protein exchange, a form of protein recycling. With re-
spect to these photobleaching results, we would like to
make clear that these assays provide no data on trafficking
that occurs within a single Golgi stack, as such trafficking
would be invisible in our assay because it does not produce
protein exchange between physically separated Golgi
units. In summary, these observations suggest a continu-
ous cycling of Golgi transmembrane proteins between
scattered Golgi stacks in microtubule-depolymerized cells.
These experiments provide positive evidence for the sec-
ond test of our hypothesis.
To provide direct experimental evidence for the ER be-
ing an intermediate in a slow Golgi protein cycling path-
way, we tested the effects of expression of the plasmid
pSar1pdnCMUIV on the distribution of Golgi glycosyl-
transferases. This plasmid codes for a dominant-negative
mutant of Sar1p, a protein required for ER export. Addi-
tion of Sar1pdn has been previously shown to block ER ex-
port both in vitro (Aridor et al., 1995) and in vivo (Pep-
perkok et al., 1998; Shima et al., 1998). Shima et al. (1998)
have previously shown that microinjection of His-tagged
Sar1pdn blocks ER export but that it has no major effects
on the distribution of Golgi cisternal components in short-
term experiments of z1 h in duration. Based on the slow
time scale of nocodazole-induced Golgi scattering, we de-
liberately assayed for Golgi effects on the slow time scale
of multiple hours. Three key effects were noted in our ex-
periments. First, preexisting Golgi structures, be they jux-
tanuclear or nocodazole scattered, as detected by immuno-
fluorescent labeling for either GalNAc-T2ÐVSV or GalT
disappeared over a time course of a few hours. Similar re-
sults have also been seen using transfected N-acetylglu-
cosaminyltransferase I as a Golgi marker in Vero cells
(Storrie, B., unpublished observations). Allowing for a
1Ð2-h Sar1pdn expression period to produce sufficient pro-
tein to disrupt cell phenotype, we estimate a half-time of
2Ð3 h for the disappearance of the juxtanuclear Golgi
staining. This half-time is reasonably consistent with the
overall half-time of nocodazole-induced Golgi scattering
and the kinetics of Golgi protein exchange in FRAP-W ex-
periments. All these are processes encompassing most, if
not all, of the scattered structures. Second, preexpression
of Sar1pdn inhibited the appearance of GalNAc-T2 in pe-
ripheral Golgi structures during nocodazole treatment.
This is a result consistent with nocodazole-induced Golgi
scattering through an ER recycling pathway. Third, disap-
pearance of preexisting Golgi structures was accompanied
by accumulation of GalNAc-T2ÐVSV in structures, giving
an ER-like staining pattern. This ER distribution certainly
included some newly synthesized GalNAc-T2. However,
the bulk of the ER-trapped GalNAc-T2 was from preex-
isting proteins that recycled from the juxtanuclear Golgi
apparatus or peripheral Golgi stacks. This contention is
based on three lines of reasoning: (a) The GalNAc-T2
time kinetics for ER accumulation were too fast for more
than a small fraction of the total ER GalNA-T2 to be
newly synthesized; the majority must be pre-existing, met-
abolically stable, GalNAc-T2 redistributed to the ER.
GalNAc-T2 antigenicity was shown to be metabolically
stable in the presence of the potent protein synthesis in-
hibitors, cycloheximide and emetine. (b) Protein synthesis
inhibitorÐlimited pulse expression of pSar1pdn was suffi-
cient to produce subsequent ER accumulation of juxta-
nuclear GalNAc-T2 in the continued presence of either
cycloheximide or emetine. (c) Microinjection of the His-
tagged Sar1pdn in the presence of emetine followed by in-
cubation in the continuous presence of emetine produced
a similar ER accumulation. In summary, these observa-
tions strongly argue that Golgi cisternal proteins cycle to
the ER with a half-time of a few hours. During nocodazole
treatment, which causes microtubule depolymerization,
this pathway continues at a substantial rate. These experi-
ments provide positive evidence for the third and fourth
tests of our hypothesis.
Our experiments indicate both a pronounced tendency
for Golgi cisternal proteins to recycle normally to the ER
and to assemble into polarized stacked Golgi cisternae.
This is a conclusion entirely consistent with our fluores-
cence and electron microscopy studies. In particular, by
electron microscopy the high labeling density of GalNAc-
T2ÐVSV in transfected HeLa cells allowed us to relate
structures to Golgi formation or cycling by content of Gal-
NAc-T2. In these studies, we observed little significant in-
crease in GalNAc-T2 labeling over the ER during the
Golgi scattering process. These data are not surprising in
view of the greater surface area of the ER relative to the
Golgi and the apparent tendency of Golgi proteins to
Òself-associateÓ into peripheral Golgi stacks in nocoda-
zole-treated cells. The membrane surface of the ER is
about fivefold greater than that of the Golgi (Griffiths et al.,
1984; Quinn et al., 1984). Any cycling Golgi protein enter-
ing the ER is diluted relative to its concentration in the
Golgi complex. Depending on kinetics of various steps in
an overall recycling process, the level of cycling Golgi pro-
tein found in the ER during Golgi scattering might not be
significantly more than that in control nonÐdrug-treated
cells. From our fluorescence studies, Golgi proteins have a
high tendency to clear from the ER into Golgi stacks. The
ER step appears to be the rapid step within an otherwise
slow overall pathway. In recent work, Cole et al. (1998)
have shown recycling to the ER of a number of Golgi-
localized VSV-Gts chimeric proteins. Our present work is
fully consistent with these observations. However, here we
show ER recycling of Golgi glycosylation enzymes, which
are resident type II transmembrane proteins, represent the
major known class of Golgi transmembrane proteins and
include all known Golgi glycosyltransferases and glycosi-
dases. Hence, our demonstration has a particular rele-The Journal of Cell Biology, Volume 143, 1998 1520
vance to the functional and structural maintenance of the
Golgi apparatus.
A Golgi-to-ER pathway presumably plays an important
role in the normal recycling of resident Golgi membrane
proteins that ÒleakÓ from the organelle. Protein retention
and potential recycling within the Golgi complex are un-
likely to be perfect. This pathway also has the potential to
be a quality control device to select against damaged Golgi
membrane proteins as they cycle through the ER. Also,
the pathway may be a consequence of the necessity to re-
cycle lipids back to the ER to be used in further rounds of
transport and membrane assembly. The recycling of resi-
dent Golgi proteins to the ER might occur by direct tran-
sient fusions between Golgi and ER membranes. We
could not detect vesicular carriers using a high-speed cam-
era, though this cannot be formally ruled out. However, if
recycling is through vesicular carriers, these would have to
fuse directly with ER membranes. Regardless of the na-
ture of the intermediates, it is clear that recycling Golgi
components reside only briefly in the ER normally and
can coalesce into a newly formed Golgi stack within min-
utes. As shown previously by immunofluorescence, this
coalescence seems to be associated with structures that on
the basis of their content of ERGIC53/p58 are likely to be
located at or about ER exit sites (Cole et al., 1996a; Yang
and Storrie, 1998; for review see Storrie and Yang, 1998).
In conclusion, we have provided strong evidence for a
novel Golgi-to-ER recycling pathway that gives a highly
plausible explanation for the nature of Golgi scattering
upon microtubule depolymerization. Establishing the mech-
anism and signals that regulate such a pathway will be a
major challenge for the future.
This project was a joint effort between the laboratories of Brian Storrie at
Virginia Tech and those of Ernst Stelzer and Tommy Nilsson at EMBL-
Heidelberg. During this project, Jamie White and Sabine Rttger were
predoctoral students at EMBL-Heidelberg, and the work of Jamie White
was jointly sponsored by Ernst Stelzer and Tommy Nilsson and that of
Sabine Rttger by Tommy Nilsson. At Virginia Tech-Blacksburg, we
would like to express our appreciation to Jeffrey Bocock, Sarah Buss,
Karen Capen, and Nolan Ko for quantification of various morphometric
measurements and fluorescence intensities. At EMBL-Heidelberg, we
would like to express our appreciation to the CCC developers: Nick
Salmon, Alfons Riedinger, Georg Ritter, Stephan Albrecht, Thomas
Stephany, and Reiner Stricker, to Ann Atzberger for FACS¨, to Anja
Habermann for cryosectioning, and to Joel Lanoix for his help on Sar1pdn
purification. We gratefully acknowledge the critical comments on the
manuscript of Rich Walker and Brenda Shirley at Virginia Tech and of
Joachim Fllekrug, Joel Lanoix, and Heidi McBride at EMBL-Heidel-
berg.
This work was supported in part by grants to the individual laboratories
and by a grant to B. Storrie from the Fogarty International Center, U.S.
National Institutes of Health while he was on sabbatical in Tommy Nils-
sonÕs laboratory.
Received for publication 27 March 1998 and in revised form 18 September
1998.
References
Aridor, M., S.J. Bannykh, T. Rowe, and W.E. Balch. 1995. Sequential coupling
between COPII and COPI vesicle coats in endoplasmic reticulum to Golgi
transport. J. Cell Biol. 131:875Ð893.
Axelrod, D., D.E. Koppel, J. Schlessinger, E. Elson, and W.W. Webb. 1976.
Mobility measurement by analysis of fluorescence photobleaching recovery
kinetics. Biophys. J. 16:1055Ð1069.
Burkhardt, J.K. 1998. The role of microtubule-based motor proteins in main-
taining the structure and function of the Golgi complex. Biochim. Biophys.
Acta. 1404:113Ð126.
Burkhardt, J.K., C.J. Echeverri, T. Nilsson, and R.B. Vallee. 1997. Overexpres-
sion of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-
dependent maintenance of membrane organelle distribution. J. Cell Biol.
139:469Ð484.
Cole, N.B., N. Sciaky, A. Marotta, J. Song, and J. Lippincott-Schwartz. 1996a.
Golgi dispersal during microtubule disruption: regeneration of Golgi stacks
at peripheral endoplasmic reticulum exit sites. Mol. Biol. Cell. 7:631Ð650.
Cole, N.B., C.L. Smith, N. Sciaky, M. Terasaki, M. Edidin, and J. Lippincott-
Schwartz. 1996b. Diffusional mobility of Golgi proteins in membranes of liv-
ing cells. Science. 273:797Ð801.
Cole, N.B., J. Ellenberg, J. Song, D. DiEuliis, and J. Lippincott-Schwartz. 1998.
Retrograde transport of Golgi localized proteins to the ER. J. Cell Biol. 140:
1Ð15.
Doms, R.W., G. Russ, and J.W. Yewdell. 1989. Brefeldin A redistributes resi-
dent and itinerant Golgi proteins to the endoplasmic reticulum. J. Cell Biol.
109:61Ð72.
Dunphy, W.G., and J.E. Rothman. 1983. Compartmentation of asparagine-
linked oligosaccharide processing in the Golgi apparatus. J. Cell Biol. 97:
270Ð275.
Dunphy, W.G., E. Fries, L.J. Urbani, and J.E. Rothman 1981. Early and late
functions associated with the Golgi apparatus reside in distinct compart-
ments.  Proc. Natl. Acad. Sci. USA. 78:7453Ð7457.
Ellenberg, J., E.J. Siggia, J.E. Moreira, C.L. Smith, J.F. Presley, H.J. Worman,
and J. Lippincott-Schwartz. 1997. Nuclear membrane dynamics and reas-
sembly in living cells: targeting of an inner nuclear membrane protein in in-
terphase and mitosis. J. Cell Biol. 138:1193Ð1206.
Fllekrug, J., and T. Nilsson. 1998. Protein sorting in the Golgi complex. Bio-
chim. Biophys. Acta. 1404:77Ð84.
Griffiths, G., G. Warren, P. Quinn, O. Mathieu-Costello, and H. Hoppeler.
1984. Density of newly synthesized plasma membrane proteins in intracellu-
lar membranes. I. Stereological studies. J. Cell Biol. 98:2133Ð2141.
Ho, W.C., V.J. Allan, G. Van Meer, E.G. Berger, and T.E. Kreis. 1989. Reclus-
tering of scattered Golgi elements occurs along microtubules. Eur. J. Cell
Biol. 48:250Ð263.
Ho, W.C., B. Storrie, R. Pepperkok, W. Ansorge, P. Karecla, and T.E. Kreis.
1990. Movement of interphase Golgi apparatus in fused mammalian cells
and its relationship to cytoskeletal elements and rearrangement of nuclei.
Eur. J. Cell Biol. 52:315Ð327.
Kreis, T.E. 1986. Microinjected antibodies against the cytoplasmic domain of
vesicular stomatitis virus glycoprotein block its transport to the cell surface.
EMBO (Eur. Mol. Biol. Organ.) J. 5:931Ð941.
Lippincott-Schwartz, J., L.C. Yuan, J.S. Bonifacino, and R.D. Klausner. 1989.
Rapid redistribution of Golgi proteins into the ER in cells treated with
brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 56:801Ð
813.
Minin, A.A. 1997. Dispersal of Golgi apparatus in nocodazole-treated fibro-
blasts is a kinesin-driven process. J. Cell Sci. 110:2495Ð2505.
Nichols, B.J., and H.R.B. Pelham. 1998. SNAREs and membrane fusion in the
Golgi apparatus. Biochim. Biophys. Acta. 1404:9Ð31.
Nilsson, T., M. Jackson, and P.A. Peterson. 1989. Short cytoplasmic sequences
serve as retention signals for transmembrane proteins in the endoplasmic
reticulum. Cell. 58:707Ð718.
Nilsson, T., M. Pypaet, M.H. Hoe, P. Slusarewicz, E.G. Berger, and G. Warren.
1993. Overlapping distribution of two glycosyltransferases in the Golgi appa-
ratus of HeLa cells. J. Cell Biol. 120:5Ð13.
Pbo, S., F. Weber, T. Nilsson, W. Schaffner, and P.A. Peterson. 1986. Struc-
tural and functional dissection of an MHC class I antigen-binding adenovirus
glycoprotein. EMBO (Eur. Mol. Biol. Organ.) J. 5:1921Ð1927.
Palade, G. 1975. Intracellular aspects of the process of protein secretion. Sci-
ence. 189:347Ð358.
Parton, R.G., K. Simon, and C.G. Dotti. 1992. Axonal and dendritic endocytic
pathways in cultured neurons. J. Cell Biol. 119:123Ð137.
Pepperkok, R., M. Lowe, B. Burke, and T.E. Kreis. 1998. Three distinct steps in
transport of vesicular stomatitis virus glycoprotein from the ER to the cell
surface in vivo with differential sensitivities to GTPgS. J. Cell Sci. 111:1877Ð
1888.
Perlman, S., and S. Penman. 1970. Mitochondrial protein synthesis: resistance
to emetine and response to RNA synthesis inhibitors. Biochem. Biophys.
Res. Commun. 40:941Ð948.
Presley, J.F., N.B. Cole, T.A. Schroer, K. Hirschberg, K.J.M. Zaal, and J. Lip-
pincott-Schwartz. 1997. ER-to-Golgi transport visualized in living cells. Na-
ture. 389:81Ð85.
Quinn, P., G. Griffiths, and G. Warren. 1984. Density of newly synthesized
plasma membrane proteins in intracellular membranes II. Biochemical stud-
ies. J. Cell Biol. 98:2142Ð2147.
Rabouille, C., N. Hui, F. Hunte, R. Kieckbusch, E.G. Berger, G. Warren, and
T. Nilsson. 1995a. Mapping the distribution of Golgi enzymes involved in the
construction of complex oligosaccharides. J. Cell Sci. 108:1617Ð1627.
Rabouille, C., T. Mistelli, R. Watson, and G. Warren. 1995b. Reassembly of
Golgi stacks from mitotic Golgi fragments in a cell-free system. J. Cell Biol.
129:605Ð618.
Rambourg, A., and Y. Clermont. 1990. Three-dimensional electron micros-
copy: structure of the Golgi apparatus. Eur. J. Cell Biol. 51:189Ð200.Storrie et al. Recycling of Golgi Glycosyltransferases through the ER 1521
Roth, J., and E.G. Berger. 1982. Immunocytochemical localization of galacto-
syltransferase in HeLa cells: codistribution with thiamine pyrophosphates in
the trans-Golgi cisternae. J. Cell Biol. 93:223Ð229.
Rothman, J.E. 1994. Mechanisms of intracellular protein transport. Nature. 372:
55Ð63.
Rttger, S., J. White, H.H. Wandall, J.-C. Olivo, A. Stark, E.P. Bennett, C.
Whitehouse, E.G. Berger, H. Clausen, and T. Nilsson. 1998. Localization of
three human polypeptide GalNAc-transferases in HeLa cells suggests initia-
tion of O-linked glycosylation throughout the Golgi apparatus. J. Cell Sci.
111:45Ð60.
Rowe, T., and W.E. Balch. 1995. Expression and purification of mammalian
Sar1. Methods Enzymol. 257:49Ð53.
Scales, S.J., R. Pepperkok, and T.E. Kreis. 1997. Visualization of ER-to-Golgi
transport in living reveals a sequential mode of action for COPII and COPI.
Cell. 90:1137Ð1148.
Sciaky, N., J. Presley, C. Smith, K.J.M. Zaal, N. Cole, J.E. Moreira, M.
Terasaki, E. Siggia, and J. Lippincott-Schwartz. 1997. Golgi tubule traffic
and the effects of brefeldin A visualized in living cells. J. Cell Biol. 139:1Ð18.
Shima, D.T., K. Haldar, R. Pepperkok, R. Watson, and G. Warren. 1997. Parti-
tioning of the Golgi apparatus during mitosis in living HeLa cells. J. Cell
Biol. 137:1211Ð1228.
Shima, D.T., N. Cabrera-Poch, R. Pepperkok, and G. Warren. 1998. An or-
dered inheritance strategy for the Golgi apparatus: visualization of mitotic
disassembly reveals a role for the mitotic spindle. J. Cell Biol. 141:955Ð966.
Storrie, B., and T.E. Kreis. 1996. Probing the mobility of membrane proteins in-
side the cell. Trends Cell Biol. 6:321Ð324.
Storrie, B., and W. Yang. 1998. Dynamics of the interphase mammalian Golgi
complex as revealed through drugs producing reversible Golgi disassembly.
Biochim. Biophys. Acta. 1404:127Ð138.
Storrie, B., R. Pepperkok, E.H.K. Stelzer, and T.E. Kreis. 1994. The intracellu-
lar mobility of a viral membrane glycoprotein measured by confocal micro-
scope fluorescence recovery after photobleaching. J. Cell Sci. 107:1309Ð1319.
Tokuyasu, K.T. 1998. A study of positive staining of ultrathin frozen sections. J.
Ultrastruct. Res. 63:287Ð307.
Turner, J.R., and A.M. Tartakoff. 1989. The response of the Golgi complex to
microtubule alterations: the roles of metabolic energy and membrane traffic
in Golgi complex organization. J. Cell Biol. 109:2081Ð2088.
Watzele, G., R. Bachoner, and E.G. Berger. 1991. Immunocytochemical local-
ization of the Golgi apparatus using protein-specific antibodies to galactosyl-
transferase. Eur. J. Cell Biol. 56:451Ð458.
Weibel, E.R. 1979. Stereological Methods. I. Practical Methods for Morphome-
try. Academic Press, London. 415 pp.
Yang, W., and B. Storrie. 1998. Scattered Golgi elements during microtubule
disruption are initially enriched in trans Golgi proteins. Mol. Biol. Cell.
9:191Ð207.